The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Open accessPublished version of a preprint
Abstract
BACKGROUND: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for surveillance and control activities. OBJECTIVE: To estimate the length of the incubation period of COVID-19 and describe its public health implications. DESIGN: Pooled analysis of confirmed COVID-19 cases reported between 4 January 2020 and 24 February 2020. SETTING: News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China. PARTICIPANTS: Persons with confirmed SARS-CoV-2 infection outside Hubei province, China. MEASUREMENTS: Patient demographic characteristics and dates and times of possible exposure, symptom onset, fever onset, and hospitalization. RESULTS: There were 181 confirmed cases with identifiable exposure and symptom onset windows to estimate the incubation period of COVID-19. The median incubation period was estimated to be 5.1 days (95% CI, 4.5 to 5.8 days), and 97.5% of those who develop symptoms will do so within 11.5 days (CI, 8.2 to 15.6 days) of infection. These estimates imply that, under conservative assumptions, 101 out of every 10 000 cases (99th percentile, 482) will develop symptoms after 14 days of active monitoring or quarantine. LIMITATION: Publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases. CONCLUSION: This work provides additional evidence for a median incubation period for COVID-19 of approximately 5 days, similar to SARS. Our results support current proposals for the length of quarantine or active monitoring of persons potentially exposed to SARS-CoV-2, although longer monitoring periods might be justified in extreme cases. PRIMARY FUNDING SOURCE: U.S. Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, and Alexander von Humboldt Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The cumulative incidence of Covid-19 cases over time among placebo and vaccine recipients begins to diverge by 12 days after the first dose, 7 days after the estimated median viral incubation period of 5 days,10 indicating the early onset of a partially protective effect of immunization.”
From Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (2020) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Jänke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,211
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Backer, J. A., Klinkenberg, D., & Wallinga, J. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.5.2000062 · Cited by 1,546
Linton, N. M., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A. R., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,376
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed · Cited by 1,277
Flagged first, then by citations
Research works printed but not linked: 1
- Varia M, 2003, CMAJ, 169, 285
Cited by
Sorted by citations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
WHO Declares COVID-19 a Pandemic.
Cucinotta, D., & Vanelli, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i1.9397 · Cited by 8,022
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Features, Evaluation and Treatment Coronavirus (COVID-19)
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020) · StatPearls · Cited by 3,351
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., Parker, M., Bonsall, D., & Fraser, C. (2020) · Science · doi:10.1126/science.abb6936 · Cited by 2,512
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960
Self-citationHigh Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
An evidence review of face masks against COVID-19
Howard, J., Huang, A., Li, Z., Tüfekçi, Z., Ždímal, V., van der Westhuizen, H., von Delft, A., Price, A. I., Fridman, L., Tang, L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014564118 · Cited by 1,577
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,744
Guzik, T. J., MOHIDDIN, S. A., Dimarco, A. D., Patel, V., Savvatis, K., Marelli‐Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,484
Kucirka, L. M., Lauer, S. A., Laeyendecker, O. B., Boon, D., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1495 · Cited by 1,414
Self-citationCOVID-19 and cardiovascular disease
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046941 · Cited by 1,738
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., BUONO, R. D., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,435
Eikenberry, S. E., Mancuso, M., Iboi, E., Phan, T., Eikenberry, K., Kuang, Y., Kostelich, E. J., & Gumel, A. B. (2020) · Infectious Disease Modelling · doi:10.1016/j.idm.2020.04.001 · Cited by 1,370
Gandhi, R. T., Lynch, J. B., & del Río, C. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009249 · Cited by 1,341
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
Larremore, D. B., Wilder, B., Lester, E., Shehata, S., Burke, J., Hay, J. A., Tambe, M., Mina, M., & Parker, R. (2020) · Science Advances · doi:10.1126/sciadv.abd5393 · Cited by 812
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Petersen, E., Koopmans, M., Go, U. Y., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Khalili, S. A., & Simonsen, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30484-9 · Cited by 1,242
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Wyllie, A. L., Fournier, J. B., Casanovas‐Massana, A., Campbell, M., Tokuyama, M., Vijayakumar, P., Warren, J. L., Geng, B., Muenker, M. C., Moore, A. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2016359 · Cited by 1,170
Coronavirus disease 2019 (COVID-19): current status and future perspectives
Li, H., Liu, S., Yu, X.-H., Tang, S., & Tang, C. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105951 · Cited by 1,211
Inferring the effectiveness of government interventions against COVID-19
Brauner, J., Mindermann, S., Sharma, M., Stephenson, A. B., Gavenčiak, T., Johnston, D., Leech, G., Salvatier, J., Altman, G., Norman, A. J., et al. (2020) · Science · doi:10.1126/science.abd9338 · Cited by 1,080
Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures
Gatto, M., Bertuzzo, E., Mari, L., Miccoli, S., Carraro, L., Casagrandi, R., & Rinaldo, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004978117 · Cited by 1,046
Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics
Peccia, J., Zulli, A., Brackney, D. E., Grubaugh, N. D., Kaplan, E. H., Casanovas‐Massana, A., Ko, A. I., Malik, A. A., Wang, D. Y. Q., Wang, M., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0684-z · Cited by 1,193
Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., et al. (2020) · Science · doi:10.1126/science.abc0035 · Cited by 993
Lamers, M. M., & Haagmans, B. L. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00713-0 · Cited by 1,066
Read, J. M., Bridgen, J. R. E., Cummings, D. A. T., Ho, A. Y. W., & Jewell, C. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0265 · Cited by 992
Kucharski, A. J., Klepac, P., Conlan, A. J. K., Kissler, S. M., Tang, M. L., Fry, H., Gog, J. R., Edmunds, W. J., Emery, J. C., Medley, G., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30457-6 · Cited by 900
SARS-CoV-2 (COVID-19) by the numbers
Bar‐On, Y. M., Flamholz, A. I., Phillips, R., & Milo, R. (2020) · eLife · doi:10.7554/elife.57309 · Cited by 1,006
COVID ‐19 and Older Adults: What We Know
Shahid, Z., Kalayanamitra, R., McClafferty, B., Kepko, D., Ramgobin, D., Patel, R. J., Aggarwal, C. S., Vunnam, R., Sahu, N., Bhatt, D., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16472 · Cited by 958
COVID-19 pandemic, coronaviruses, and diabetes mellitus
Muniyappa, R., & Gubbi, S. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2020 · Cited by 937
COVID-19 Vaccine: A comprehensive status report
Kaur, S. P., & Gupta, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198114 · Cited by 870
Badr, H. S., Du, H., Marshall, M., Dong, E., Squire, M. M., & Gardner, L. M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30553-3 · Cited by 851
Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions
Dehning, J., Zierenberg, J., Spitzner, F. P., Wibral, M., Neto, J. P., Wilczek, M., & Priesemann, V. (2020) · Science · doi:10.1126/science.abb9789 · Cited by 836
COVID-19 and diabetes: Knowledge in progress
Hussain, A., Bhowmik, B., & Moreira, N. C. D. V. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108142 · Cited by 836
Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate
Courtemanche, C., Garuccio, J., Le, A., Pinkston, J. C., & Yelowitz, A. S. (2020) · Health Affairs · doi:10.1377/hlthaff.2020.00608 · Cited by 773
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
Meyerowitz, E. A., Richterman, A. G., Gandhi, R. T., & Sax, P. E. (2020) · Annals of Internal Medicine · doi:10.7326/m20-5008 · Cited by 783
Miller, S. L., Nazaroff, W. W., Jimenez, J. L., Boerstra, A., Buonanno, G., Dancer, S. J., Kurnitski, J., Marr, L. C., Morawska, L., & Noakes, C. (2021) · Indoor Air · doi:10.1111/ina.12751 · Cited by 734
Lyu, W., & Wehby, G. L. (2020) · Health Affairs · doi:10.1377/hlthaff.2020.00818 · Cited by 721
How COVID-19 induces cytokine storm with high mortality
Hojyo, S., Uchida, M., Tanaka, K., Hasebe, R., Tanaka, Y., Murakami, M., & Hirano, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00146-3 · Cited by 663
Islam, M. Z., Islam, M. M., & Asraf, A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100412 · Cited by 729
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y. F., Chien, C., Yarmishyn, A. A., Lin, Y., Luo, Y., Lin, Y.-T., Lai, W.-Y., Yang, D., Chou, S., Yang, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 702
Covasim: An agent-based model of COVID-19 dynamics and interventions
Kerr, C. C., Stuart, R. M., Mistry, D., Abeysuriya, R., Rosenfeld, K., Hart, G. R., Núñez, R. C., Cohen, J. A., Selvaraj, P., Hagedorn, B., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009149 · Cited by 729
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Tenforde, M. W., Self, W. H., Adams, K., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2021) · JAMA · doi:10.1001/jama.2021.19499 · Cited by 633
Pung, R., Chiew, C. J., Young, B. E., Chin, S. N. M., Chen, M. I.-C., Clapham, H., Cook, A. R., Maurer‐Stroh, S., Toh, M. P. H., Poh, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30528-6 · Cited by 648
Zhang, J., Litvinova, M., Wang, W., Wang, Y., Deng, X., Chen, X., Li, M., Zheng, W., Yi, L., Chen, X., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30230-9 · Cited by 655
Hamner, L., Dubbel, P., Capron, I., Ross, A., Jordan, A., Lee, J., Lynn, J., Ball, A., Narwal, S., Russell, S., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6919e6 · Cited by 638
Gollwitzer, A., Martel, C., Brady, W. J., Pärnamets, P., Freedman, I. G., Knowles, E. D., & Van Bavel, J. J. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-00977-7 · Cited by 609
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Machhi, J., Herskovitz, J., Senan, A. M., Dutta, D., Nath, B., Oleynikov, M. D., Blomberg, W. R., Meigs, D. D., Hasan, M., Patel, M., et al. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09944-5 · Cited by 642
Zhu, Z., Lian, X., Su, X., Wu, W., Marraro, G. A., & Zeng, Y. (2020) · Respiratory Research · doi:10.1186/s12931-020-01479-w · Cited by 637
Islam, N., Sharp, S. J., Chowell, G., Shabnam, S., Kawachi, I., Lacey, B., Massaro, J. M., D’Agostino, R. B., & White, M. (2020) · BMJ · doi:10.1136/bmj.m2743 · Cited by 601
Modeling COVID-19 scenarios for the United States
IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1132-9 · Cited by 556
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiß, C., Carrière, M., Fusco, L., Capua, I., Regla-Nava, J. Á., Pasquali, M., Scott, J. A., Vitale, F., Ünal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 605
Katsoularis, I., Fonseca-Rodríguez, O., Farrington, P., Lindmark, K., & Fors Connolly, A.-M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00896-5 · Cited by 582
A Systematic Review of COVID-19 Epidemiology Based on Current Evidence
Park, M., Cook, A. R., Lim, J. T., Sun, Y., & Dickens, B. S. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040967 · Cited by 606
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138996 · Cited by 600
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Ngonghala, C. N., Iboi, E., Eikenberry, S. E., Scotch, M., MacIntyre, C. R., Bonds, M. H., & Gumel, A. B. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108364 · Cited by 553
Temporal Detection and Phylogenetic Assessment of SARS-CoV-2 in Municipal Wastewater
Nemudryi, A. A., Nemudraia, A., Wiegand, T., Surya, K., Buyukyoruk, M., Cicha, C., Vanderwood, K. K., Wilkinson, R. A., & Wiedenheft, B. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100098 · Cited by 528
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
Oran, D. P., & Topol, E. J. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6976 · Cited by 553
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Killingley, B., Mann, A., Kalinova, M., Boyers, A., Goonawardane, N., Zhou, J., Lindsell, K., Hare, S. S., Brown, J. C., Frise, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01780-9 · Cited by 532
Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research
McAloon, C. G., Collins, Á. B., Hunt, K., Barber, A. M., Byrne, A. W., Butler, F., Casey-Bryars, M., Griffin, J., Lane, E. A., McEvoy, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039652 · Cited by 519
Sun, K., Chen, J., & Viboud, C. G. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30026-1 · Cited by 523
Khader, Y. S., Nsour, M. A., Al-Batayneh, O. B., Saadeh, R., Bashier, H., Alfaqih, M. A., Al-Azzam, S. I., & AlShurman, B. A. (2020) · JMIR Public Health and Surveillance · doi:10.2196/18798 · Cited by 517
Buzhdygan, T. P., DeOre, B. J., Baldwin‐Leclair, A., Bullock, T. A., McGary, H. M., Khan, J. A., Razmpour, R., Hale, J. F., Galie, P. A., Potula, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105131 · Cited by 513
Furukawa, N. W., Brooks, J. T., & Sobel, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.201595 · Cited by 505
Park, S. E. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.00493 · Cited by 527
Jing, Q.-L., Liu, M.-J., Zhang, Z.-B., Fang, L.-Q., Yuan, J., Zhang, A.-R., Dean, N. E., Luo, L., Ma, M.-M., Longini, I. M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30471-0 · Cited by 492
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19
Böger, B., Fachi, M. M., Vilhena, R. D. O., Cobre, A. D. F., Tonin, F. S., & Pontarolo, R. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.07.011 · Cited by 520
Epidemiology and transmission dynamics of COVID-19 in two Indian states
Laxminarayan, R., Wahl, B., Dudala, S. R., Gopal, K., Mohan B, C., Neelima, S., Jawahar Reddy, K. S., Radhakrishnan, J., & Lewnard, J. A. (2020) · Science · doi:10.1126/science.abd7672 · Cited by 485
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis
Alfano, V., & Ercolano, S. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00596-3 · Cited by 481
Fernández‐de‐las‐Peñas, C., Palacios‐Ceña, D., Gómez‐Mayordomo, V., Cuadrado, M. L., & Florêncio, L. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052621 · Cited by 504
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Lou, B., Li, T., Zheng, S., Su, Y., Li, Z., Liu, W., Yu, F., Ge, S., Zou, Q., Yuan, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00763-2020 · Cited by 494
Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US
Auger, K. A., Shah, S. S., Richardson, T., Hartley, D., Hall, M., Warniment, A., Timmons, K. M., Bosse, D., Ferris, S. A., Brady, P. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.14348 · Cited by 481
The benefits and costs of using social distancing to flatten the curve for COVID-19
Thunström, L., Newbold, S. C., Finnoff, D., Ashworth, M., & Shogren, J. F. (2020) · Journal of Benefit-Cost Analysis · doi:10.1017/bca.2020.12 · Cited by 439
Pre-symptomatic detection of COVID-19 from smartwatch data
Mishra, T., Wang, M., Metwally, A. A., Bogu, G. K., Brooks, A., Bahmani, A. H., Alavi, A., Celli, A., Higgs, E., Dagan‐Rosenfeld, O., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00640-6 · Cited by 484
Ortiz-Prado, E., Simbaña-Rivera, K., Gómez- Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., et al. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115094 · Cited by 458
Baj, J., Karakuła‐Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., Forma, A., Karakuła, K. H., Flieger, W., Portincasa, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061753 · Cited by 480
Flattening the COVID-19 peak: Containment and mitigation policies
OECD (2020) · OECD policy responses to coronavirus (Covid-19) · doi:10.1787/e96a4226-en · Cited by 454
Paltiel, A. D., Zheng, A., & Walensky, R. P. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16818 · Cited by 451
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
Escobar, L. E., Molina-Cruz, A., & Barillas-Mury, C. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008410117 · Cited by 437
Severe covid-19 pneumonia: pathogenesis and clinical management
Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M., & Hatipoglu, U. S. (2021) · BMJ · doi:10.1136/bmj.n436 · Cited by 452
Matrajt, L., & Leung, T. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201093 · Cited by 445
COVID-19 Outbreak: An Overview
Ciotti, M., Angeletti, S., Minieri, M., Giovannetti, M., Benvenuto, D., Pascarella, S., Sagnelli, C., Bianchi, M., Bernardini, S., & Ciccozzi, M. (2019) · Chemotherapy · doi:10.1159/000507423 · Cited by 453
Epidemiology and clinical features of COVID-19: A review of current literature
Siordia, J. A. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104357 · Cited by 441
Bosco‐Lauth, A. M., Hartwig, A. E., Porter, S. M., Gordy, P., Nehring, M., Byas, A. D., VandeWoude, S., Ragan, I. K., Maison, R. M., & Bowen, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013102117 · Cited by 417
SARS-CoV-2 viral load and shedding kinetics
Puhach, O., Meyer, B., & Eckerle, I. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00822-w · Cited by 462
Vaccine optimization for COVID-19: Who to vaccinate first?
Matrajt, L., Eaton, J., Leung, T., & Brown, E. R. (2021) · Science Advances · doi:10.1126/sciadv.abf1374 · Cited by 426
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C. M., Krassowska, K., Fox, R. A., Binnian, I., Glover, V., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00160-0 · Cited by 426
Face masks considerably reduce COVID-19 cases in Germany
Mitze, T., Kosfeld, R., Rode, J., & Wälde, K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015954117 · Cited by 457
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Younes, N., Al‐Sadeq, D. W., Al-Jighefee, H. T., Younes, S. N., Al-Jamal, O., Daas, H. I., Yassine, H. M., & Nasrallah, G. K. (2020) · Viruses · doi:10.3390/v12060582 · Cited by 449
Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies
Domenico, L. D., Pullano, G., Sabbatini, C. E., Boëlle, P., & Colizza, V. (2020) · BMC Medicine · doi:10.1186/s12916-020-01698-4 · Cited by 419
COVID-19 diagnostics in context
Weissleder, R., Lee, H., Ko, J., & Pittet, M. J. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc1931 · Cited by 415
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Aleem, A., Samad, A., & Slenker, A. K. (2021) · Europe PMC (PubMed Central) · Cited by 398
Effective health communication – a key factor in fighting the COVID-19 pandemic
Finset, A., Bosworth, H. B., Butow, P. N., Gulbrandsen, P., Hulsman, R. L., Pieterse, A. H., Street, R. L., Tschötschel, R., & van Weert, J. C. M. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.03.027 · Cited by 416
Silva, P. C. D. L. E., Batista, P. V. D. C., Lima, H. S., Alves, M. A., Guimarães, F. G., & Silva, R. (2020) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2020.110088 · Cited by 390
Metadata
- Authors
- Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J.
- Affiliations
- Johns Hopkins University (US)
- University of Massachusetts Amherst (US)
- Corresponding author
- Lessler, Justin
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2020-05-05
- Volume
- 172
- Issue
- 9
- Pages
- 577-582
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- PMC
- PMC7081172
- OpenAlex
- W3010233963
- Cited by
- 5,970
- References
- 26
- Citations by year
- 2026: 64 · 2025: 131 · 2024: 249 · 2023: 453 · 2022: 938 · 2021: 1871 · 2020: 2257
- FWCI
- 219.21
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nd
- Locations
- Annals of Internal Medicine (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ScholarWorks@UMassAmherst (University of Massachusetts Amherst) (submittedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion)
- ScholarWorks@UMassAmherst (University of Massachusetts Amherst) (submittedVersion, other-oa)
- Funders
- Alexander von Humboldt-Stiftung
- Johns Hopkins University
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of General Medical Sciences (R35GM119582)
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, incubation period, symptom onset, quarantine duration, active monitoring, confirmed cases, disease surveillance, disease control
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, China, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Retrospective Studies, Coronavirus Infections, Infectious Disease Incubation Period, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
